307 results on '"von Hahn, Thomas"'
Search Results
2. Flexible endoscopic treatment of Zenker’s diverticulum—a retrospective, observational multicenter study
3. Safety and efficacy of conventional compared to segmented esophageal fully covered self-expanding metal stents: a retrospective multicenter case–control study
4. Biliary drainage in palliative and curative intent European patients with hilar cholangiocarcinoma and malignant hilar obstruction: a retrospective single center analysis
5. Cold Versus Hot Snare Endoscopic Resection of Large Nonpedunculated Colorectal Polyps: Randomized Controlled German CHRONICLE Trial
6. Predictive Factors for the Outcome of Unsupervised Endoscopic Submucosal Dissection During the Initial Learning Curve with Prevalence-Based Indication
7. Learning curve of endoscopic submucosal dissection (ESD) with prevalence-based indication in unsupervised Western settings: a retrospective multicenter analysis
8. Genetic and pharmacological perturbation of hepatitis-C virus entry
9. Characteristics and endoscopic treatment of interventional and non-interventional iatrogenic colorectal perforations in centers with high endoscopic expertise: a retrospective multicenter study
10. Surgical Procedures in Patients Awaiting Liver Transplantation: Complications and Impact on the Liver Function
11. Cold versus Hot Snare Endoscopic Resection of Large Non-Pedunculated Colorectal Polyps (Randomized-controlled German CHRONICLE-trial)
12. Impact of a simple non-invasive nasal mask device on intraprocedural hypoxemia in overweight individuals undergoing upper gastrointestinal endoscopy with sedation provided by a non-anesthesiologist provider
13. Metabolomics analysis reveals novel serum metabolite alterations in cancer cachexia
14. Ipsilateral access portal venous embolization (PVE) for preoperative hypertrophy exhibits low complication rates in Clavien-Dindo and CIRSE scales
15. Diagnostische und prognostische Bedeutung des α-Feto-Proteins beim hepatozellulären Karzinom
16. Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells
17. SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations
18. Parenchyma-Preserving Hepatectomy in Perihilar Cholangiocarcinoma: A Chance for Critical Patients?
19. Provider-reported Use of Butylscopolamine in Gastrointestinal Endoscopy in Germany
20. Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
21. Erkrankungen und Diagnostik der Gallenwege: Wann braucht der Gastroenterologe den Radiologen?
22. Parasitosen und bakterielle Lebererkrankungen
23. Expression Cloning of Host Factors Required for the HCV Replication Cycle
24. Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers
25. Hepatitis D virus infection, innate immune response and antiviral treatments in stem cell‐derived hepatocytes.
26. Oxidized Low-Density Lipoprotein Is a Novel Predictor of Interferon Responsiveness in Chronic Hepatitis C Infection
27. Learning curve of endoscopic submucosal dissection (ESD) with prevalence-based indication in unsupervised Western settings: a retrospective multicenter analysis
28. Percutaneous transhepatic or endoscopic ultrasound-guided biliary drainage in malignant distal bile duct obstruction using a self-expanding metal stent: Study protocol for a prospective European multicenter trial (PUMa trial)
29. Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization
30. Hepatitis D virus infection of stem cell-derived hepatocytes triggers an IFN- and NFκB-based innate immune response unable to clear infection
31. Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro
32. Hepatocytes That Express Variants of Cyclophilin A Are Resistant to HCV Infection and Replication
33. Second-wave Protease Inhibitors: Choosing an Heir
34. Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators
35. Relevance of Resistance Against Direct Acting Antiviral Agents in Hepatitis C Virus Infection – What Technology do we Really Need in Clinical Practice?
36. Parasitosen und bakterielle Lebererkrankungen
37. Cationic amphiphilic drugs enhance entry of lentiviral particles pseudotyped with rabies virus glycoprotein into non-neuronal cells
38. Novel therapies for hepatitis C — one pill fits all?
39. Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity
40. Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity
41. The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
42. Surgical Procedures in Patients Awaiting Liver Transplantation: Complications and Impact on the Liver Function
43. Improving Outcomes in Perihilar Cholangiocarcinoma
44. Klatskin Tumors: Challenging as Ever
45. Characterization of the inhibition of hepatitis C virus entry by In vitro–generated and patient-derived oxidized low-density lipoprotein
46. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry
47. Survival of The Fittest: Selection of Hepatitis C Virus Variants During Liver Graft Reinfection
48. Filovirus Antiviral Activity of Cationic Amphiphilic Drugs Is Associated with Lipophilicity and Ability To Induce Phospholipidosis
49. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry
50. Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A#
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.